Search results
Cipla Ltd. is one of the leading pharmaceutical companies in India, offering a wide range of products and services. Find out the latest news, stock price, charts, expert views, forecasts, and more ...
Annual Reports for 2022-2023. Annual Report 2022-23 (Single page) Annual Report 2022-23 (Double page) Notice of Annual General Meeting. Scrutinizer report of the 87th Annual General Meeting. Address by Dr. Y K Hamied, Chairman at the 87th Annual General Meeting. Presentation by Mr. Umang Vohra – MD & GCEO at the 87th Annual General Meeting.
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013. CIN: L24239MH1935PLC002380. +91 22 24826000 | +91 22 24826701 | +91 22 24826300. Send a Query. Listing Equity Shares: BSE Limited and National Stock. Exchange of India Limited.
Company Secretary Cipla Limited Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013 Tel: (022) 2482 6000 E-mail: cosecretary@cipla.com
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
Cipla is a leading pharmaceutical from India with presence across the world. It was established in 1935 as Chemical Industrial & Pharmaceutical Laboratories Ltd and changed to its current name in 1984. The company has a vast portfolio with more than 1,500 products in the market. The company’s business is divided into three strategic units ...
With its 50+ years’ experience in manufacturing APIs, Cipla has produced 200+ generics and complex APIs. Our API Business covers 60 countries across the globe. The Company continues to be a preferred partner to some of the largest generic formulators globally due to our focus on niche molecules and quality. A strong dedicated team of over 250 ...
